Table 2

Statin utilisation according to age and indication among TILDA participants (wave 1) aged over 50 years (n=5618)

Age (years)NumberNumber on statins% taking statins (95% CI)MIIHDStrokePACDiabetesHypertensionHigh cholesterolNo diagnosis
50–64338776522.6%
(21.2 to 24.0)
562925737122725129
65–74148861141.1
(38.6 to 43.6)
725639606114713634
75+74333945.6
(42.1 to 49.2)
5747285128733019
Total5618171530.5
(29.3 to 31.7)
1851329218416044741782
Total with diagnosis whether on statins or not25017915048427712849452007
% of those with indication on statins (95% CI)74.0 
(68.2 to 79.1)
73.7 
(66.7 to 79.7)
61.3 
(53.2 to 68.9)
38.0 
(33.8 to 42.4)
57.8 
(51.8 to 63.5)
34.8 
(32.3 to 37.5)
44.1 
(41.0 to 47.3)
4.1 
(3.3 to 5.0)
% of those on statins with indication10.97.85.410.89.426.324.54.8
  • The column ‘Number’ represents the total number of individuals in the TILDA dataset by age group and overall, whether they are taking a statin or not, while the column ‘Number on statins’ represents the total number of individuals taking a statin. The column ‘% taking statins’ is the number on statins as a percentage of all individuals by age group and overall. The subsequent eight columns present the numbers or percentages on statins for each of the indication categories.

  • IHD, ischaemic heart disease; MI, myocardial infarction; PAC, potential atherosclerotic conditions; TILDA, Analysis of  The Irish Longitudinal Study on Ageing.

  • Source: TILDA wave 1 data.